XML 34 R16.htm IDEA: XBRL DOCUMENT v3.19.1
Derivative Financial Instruments
12 Months Ended
Dec. 31, 2018
Derivative Instruments and Hedging Activities Disclosure [Abstract]  
DERIVATIVE FINANCIAL INSTRUMENTS

NOTE 10 – DERIVATIVE FINANCIAL INSTRUMENTS

 

Derivative financial instruments are comprised of (i) the fair value of conversion features embedded in convertible promissory notes for which the conversion rate is not fixed, but instead is adjusted based on a discount to the market price of the Company’s common stock, and (ii) the fair value of certain warrants issued in connection with the July 2018 Private Placement (as defined in Note 11) for which the exercise price or the number of shares issuable was not fixed upon the issuance of the warrants. The fair market value of derivative liabilities related to convertible promissory notes was calculated at inception of each convertible promissory note for which the conversion rate was not fixed and allocated to the components of the respective convertible notes, with any excess recorded as a charge to “Financing cost.” The fair market value of derivative liabilities related to warrants issued in the July 2018 Private Placement was initially allocated to the proceeds of the transaction. When the exercise price and number of shares became fixed in September 2018, the fair value of the warrants was reallocated to shareholders’ equity. Derivative financial instruments are revalued at the end of each period, with the change in value recorded to “Change in fair value of on derivative financial instruments.”

  

Derivative financial instruments recorded in years ended December 31, 2018 include the following:

 

           Change in         
   Fair Value   Inception of   Fair Value   Extinguishment   Fair Value 
   as of   Derivative   of Derivative   of Derivative   as of 
   December 31,   Financial   Financial   Financial   December 31, 
   2017   Instruments   Instruments   Instruments   2018 
                     
$53k Note - July 2017  $48,876   $---   $5,017   $(53,893)  $--- 
$35k Note - September 2017   36,161    ---    1,108    (37,269)   --- 
$55k Note - September 2017   64,656    ---    5,032    (69,688)   --- 
$53k Note #2 - October 2017   58,216    ---    (2,427)   (55,789)   --- 
$171.5k Note - October 2017   190,580    ---    (108,201)   147,523    229,902 
$57.8k Note - January 2018   ---    82,652    (19,103)   (63,549)   --- 
$112.8k Note - February 2018   ---    161,527    (20,565)   (140,962)   --- 
$83k Note - February 2018   ---    119,512    (12,792)   (106,720)   --- 
$105k Note - March 2018   ---    153,371    (17,196)   (136,175)   --- 
$63k Note - April 2018   ---    83,806    (11,469)   (72,337)   --- 
$57.8k Note - April 2018   ---    83,397    (8,968)   (74,429)   --- 
$90k Note - April 2018   ---    130,136    (7,106)   (123,030)   --- 
$53k Note II - April 2018   ---    71,679    (12,147)   (59,532)   --- 
$68.3k Note - May 2018   ---    99,422    (8,290)   (91,132)   --- 
$37k Note - May 2018   ---    54,086    (6,323)   (47,763)   --- 
$63k Note II - May 2018   ---    90,390    (9,373)   (81,017)   --- 
$78.8k Note - May 2018   ---    116,027    (15,358)   (100,669)   --- 
$2M PIPE - July 2018   ---    2,397,516    385,856    (2,783,372)   --- 
$103k Note I - October 2018   ---    143,834    (12,217)   ---    131,617 
$103k Note II - November 2018   ---    142,915    (7,070)   ---    135,845 
$153k Note - November 2018   ---    166,378    (8,952)   ---    157,426 
$103k Note III - December 2018   ---    148,965    (3,315)   ---    145,650 
                          
   $398,489   $4,245,613   $106,141   $(3,949,803)  $800,440 

 

Fair market value of the derivative financial instruments is measured using the Black-Scholes pricing model with the following assumptions: risk-free interest rate of 1.21% to 2.73%, expected life of 0.01 to 1.17 years, volatility of 172.67% to 303.06%, and expected dividend yield of zero. The entire amount of derivative instrument liabilities is classified as current due to the fact that settlement of the derivative instruments could be required within twelve months of the balance sheet date.